Selective bladder-preserving therapy for muscle-invasive cancer

被引：3
|
作者：
Heney, Niall M. [1 ]
Kaufman, Donald S. [1 ]
Shipley, William U. [1 ]
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Dept Radiat Oncol, Sch Med, Boston, MA 02114 USA
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2009年 / 6卷 / 04期
关键词：
NEOADJUVANT CHEMOTHERAPY; TRANSURETHRAL RESECTION; RADIATION-THERAPY; ONCOLOGY-GROUP; PRESERVATION; CONSERVATION;
D O I：
10.1038/nrclinonc.2009.21
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Transurethral resection of the bladder and adjuvant chemoradiation can permit eradication of the tumor and micrometastases. close monitoring by sequential cystoscopy and biopsy can achieve similar survival outcomes to radical cystectomy, and could avoid invasive treatment.
引用
收藏
页码：193 / 194
页数：2
相关论文
共 50 条
  • [1] Selective bladder-preserving therapy for muscle-invasive cancer
    Niall M. Heney
    Donald S. Kaufman
    William U. Shipley
    [J]. Nature Reviews Clinical Oncology, 2009, 6 : 193 - 194
  • [2] Bladder-Preserving Radiation Therapy for Elderly Patients With Muscle-Invasive Bladder Cancer
    Kreofsky, C. R.
    Merrell, K. W.
    Choo, C. S.
    Mutter, R. W.
    Pisansky, T. M.
    Davis, B. J.
    Choo, R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E222 - E223
  • [3] Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer
    Onozawa, Mizuki
    Miyanaga, Naoto
    Hinotsu, Shiro
    Miyazaki, Jun
    Oikawa, Takehiro
    Kimura, Tomokazu
    Takaoka, Ei-ichiro
    Kawai, Koji
    Shimazui, Toru
    Sakurai, Hideyuki
    Nishiyama, Hiroyuki
    Akaza, Hideyuki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (09) : 825 - 830
  • [4] Current state of the art: Bladder-preserving trimodality therapy for muscle-invasive bladder cancer
    Efstathiou, Jason A.
    [J]. CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [5] Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Konieczkowski, David J.
    Efstathiou, Jason A.
    Mouw, Kent W.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (03) : 567 - 584
  • [6] Bladder-preserving therapy for muscle-invasive bladder cancer: Should it be recommended to appropriate patients?
    Hideyuki Akaza
    [J]. Current Urology Reports, 2008, 9 (4) : 257 - 258
  • [7] Vinorelbine in Bladder-Preserving Multimodality Treatment for Muscle-Invasive Bladder Cancer
    Arnold, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1150 - S1150
  • [8] Surgical bladder-preserving techniques in the management of muscle-invasive bladder cancer
    Lyons, Matthew D.
    Smith, Angela B.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (06) : 262 - 270
  • [9] Nomograms Predicting Response to Therapy and Outcomes After Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Coen, John J.
    Paly, Jonathan J.
    Niemierko, Andrzej
    Kaufman, Donald S.
    Heney, Niall M.
    Spiegel, Daphne Y.
    Efstathiou, Jason A.
    Zietman, Anthony L.
    Shipley, William U.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (02): : 311 - 316
  • [10] THE TOLERABILITY AND EFFICACY OF BCG ADMINISTRATION AFTER RECURRENCE IN BLADDER-PRESERVING THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
    Xie, Ruiyang
    Wu, Jie
    Cui, Honglei
    Tang, Ping
    Zhong, Sijing
    Shi, Hongzhe
    Guan, Youyan
    Zhou, Aiping
    Liu, Yueping
    Shou, Jianzhong
    [J]. JOURNAL OF UROLOGY, 2023, 209 : E239 - E239
12345